Overexpression of VCC-1 gene in human hepatocellular carcinoma cells promotes cell proliferation and invasion

被引:26
|
作者
Mu, Xia [1 ,2 ]
Chen, Yao [1 ]
Wang, Shuihai [1 ]
Huang, Xiang [1 ]
Pan, Huazhen [1 ]
Li, Ming [1 ]
机构
[1] So Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China
[2] Guizhou Prov Ctr Dis Prevent & Control, Inst Infect Dis, Guiyang 550004, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
chemokine; hepatocellular carcinoma; VCC-1; tumorigenesis; CHEMOKINE; ANGIOGENESIS; GROWTH; LINE;
D O I
10.1093/abbs/gmp051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor-correlated chemokine 1 (VCC-1), a novel chemokine, is hypothesized to be associated with carcinogenesis. VCC-1 is expressed in hepatocellular carcinoma (HCC) cells, but its function remains unknown. To investigate the molecular effects of VCC-1 on HCC cells, the HCC cell line SMMC7721 was stably transfected with the recombinant plasmid pcDNA3.1/VCC-1. Our data demonstrated that overexpression of VCC-1 in SMMC7721 cells significantly enhanced the cellular proliferation, invasive ability, and tumor growth, when compared with both empty vector control cells and parental cells. These results strongly suggest that VCC-1 plays an important role in SMMC7721 invasion and tumor growth, and indicate that VCC-1 may serve as a potential biomarker for anti-HCC therapies.
引用
收藏
页码:631 / 637
页数:7
相关论文
共 50 条
  • [1] Overexpression of Rab25 promotes hepatocellular carcinoma cell proliferation and invasion
    Geng, Donghua
    Zhao, Wenyan
    Feng, Yong
    Liu, Jingang
    TUMOR BIOLOGY, 2016, 37 (06) : 7713 - 7718
  • [2] Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway
    Geng, Donghua
    Zhao, Wenyan
    Feng, Yong
    Liu, Jingang
    TUMOR BIOLOGY, 2016, 37 (03) : 3341 - 3347
  • [3] Overexpression of engulfment and cell motility 1 promotes cell invasion and migration of hepatocellular carcinoma
    Jiang, Jiarui
    Liu, Guoqing
    Miao, Xiongying
    Hua, Songwen
    Zhong, Dewu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (03) : 505 - 511
  • [4] Overexpression of TAF1L Promotes Cell Proliferation, Migration and Invasion in Esophageal Squamous Cell Carcinoma
    Zhong, Shan
    Yan, Hongfei
    Chen, Zhengshan
    Li, Yanpeng
    Shen, Yanqin
    Wang, Yongyu
    Li, Lan
    Sheng, Sitong
    Wang, Yun
    JOURNAL OF CANCER, 2019, 10 (04): : 979 - 989
  • [5] Overexpression of interleukin-32 promotes invasion by modulating VEGF in hepatocellular carcinoma
    Zhao, Wen-Bo
    Wang, Quan-Li
    Xu, Yan-Tian
    Xu, Shi-Feng
    Qiu, Yang
    Zhu, Feng
    ONCOLOGY REPORTS, 2018, 39 (03) : 1155 - 1162
  • [6] MACC1-AS1 promotes hepatocellular carcinoma cell invasion and proliferation by regulating PAX8
    Tong, Hui
    Liu, Xiaohui
    Li, Tao
    Qiu, Weihua
    Peng, Chenghong
    Shen, Baiyong
    Zhu, Zhecheng
    AGING-US, 2020, 12 (01): : 70 - 79
  • [7] PTK6 promotes hepatocellular carcinoma cell proliferation and invasion
    Chen, Xiaohong
    Song, Bo
    Lin, Yuanlong
    Cao, Lijun
    Feng, Shiyan
    Zhang, Lin
    Wang, Fuxiang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (10): : 4354 - 4361
  • [8] Echinococcus granulosus protoscoleces promotes proliferation and invasion of hepatocellular carcinoma cells
    Yasen, Aimaiti
    Wang, Maolin
    Ran, Bo
    Lv, Guodong
    Aji, Tuerganaili
    Xiao, Hui
    Shao, Yingmei
    Wen, Hao
    CYTOTECHNOLOGY, 2021, 73 (01) : 13 - 22
  • [9] Overexpression of NEDD9 promotes cell invasion and metastasis in hepatocellular carcinoma
    Zhou, Senjun
    Xu, Ming
    Shen, Jiliang
    Liu, Xiaolong
    Chen, Mingming
    Cai, Xiujun
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (06) : 677 - 686
  • [10] Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness
    Xu, Y.
    Chen, Q.
    Li, W.
    Su, X.
    Chen, T.
    Liu, Y.
    Zhao, Y.
    Yu, C.
    ONCOGENE, 2010, 29 (23) : 3386 - 3397